CytomX Therapeutics (STU:6C1) Other Long Term Assets : €0.9 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is CytomX Therapeutics Other Long Term Assets?

CytomX Therapeutics's other long-term assets for the quarter that ended in Mar. 2024 was €0.9 Mil.

CytomX Therapeutics's quarterly other long-term assets declined from Sep. 2023 (€0.9 Mil) to Dec. 2023 (€0.9 Mil) but then increased from Dec. 2023 (€0.9 Mil) to Mar. 2024 (€0.9 Mil).

CytomX Therapeutics's annual other long-term assets declined from Dec. 2021 (€1.6 Mil) to Dec. 2022 (€0.9 Mil) but then increased from Dec. 2022 (€0.9 Mil) to Dec. 2023 (€0.9 Mil).

CytomX Therapeutics Other Long Term Assets Historical Data

The historical data trend for CytomX Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytomX Therapeutics Other Long Term Assets Chart

CytomX Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

2.64

2.54

1.61

0.89

0.92

CytomX Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															0.88	0.93	0.94	0.92	0.92

CytomX Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

CytomX Therapeutics (STU:6C1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CytomX Therapeutics Inc (STU:6C1) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

CTMX:USA 6C1:Germany

Address

151 Oyster Point Boulevard, Suite 400, South San Francisco, CA, USA, 94080

Website

https://www.cytomx.com

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

CytomX Therapeutics (STU:6C1) Headlines

No Headlines